Tribunjogja.com – The World Health Organization (WHO) has projected that the world must prepare for an aging society.
Between 2015 and 2050, the proportion of the world’s population over 60 will almost double from 12 percent to 22 percent.
By 2030, 1 in 6 people in the world will be 60 years or older.
The number of people aged 80 or over is expected to triple between 2020 and 2050 to reach 426 million.
With the rate of aging accelerating, one of the major challenges facing all countries is ensuring the readiness of health and social systems.
Read also: Johnson & Johnson Indonesia Supports the Implementation of PRIDE UMN 2022
Aging is the result of damage to molecules and body cells over time which results in an increased risk of disease and death.
One of several diseases that attack in old age is cancer blood.
Blood accounts for about 8 percent of our normal body weight and serves to supply oxygen, nutrients, hormones and antibodies throughout the body.
Blood consists of a mixture of plasma and cells blood (sel blood red, cell blood white and platelets). Cancer is caused by a dysfunction in cell growth.
In a healthy body, cells blood new whites are regularly produced to replace old and damaged ones, but in patients cancer blood cell production or growth occurs blood too much.
Johnson & Johnson has been dedicated to helping build a better world for more than 130 years, helping to address some of the toughest health challenges facing humanity, including cancer .
Continuing its commitment to raise awareness of the dangers of blood cancer for the elderly and in commemoration of the world blood cancer day which falls on 28 May 2022 and the national elderly day which falls on 29 May 2022, PT Johnson & Johnson Indonesia held a webinar for the media. with the theme “Love Our Elderly with Early Detection of Blood Cancer”.
Read also: Cooperating with PAFI, Johnson & Johnson Indonesia Again Holds National Pharmacy Webinar
This event is a continuation of a similar campaign that has been carried out since 2021.
Country Leader of Communication and Public Affairs dari PT Johnson & Johnson Indonesia, Devy Yheanne in his remarks said, “Johnson & Johnson continues to be committed to addressing the public health crisis and working to change the cancer from a deadly disease to a preventable and curable disease. Resources, networks and support from academia, government and other health organizations help to address the challenges. Johnson & Johnson continue to develop new and innovative solutions in pharmaceuticals and medical devices.”
Understanding of danger cancer blood For the elderly, it is very necessary especially with the growth rate elderly which is faster.
Indonesia, which is the fourth most populous country in the world, must also be prepared to face an increase in the number of elderly people which is estimated to be 11 percent in 2035.
In more developed countries, the total number of new cases cancer blood occurring in people aged 70 years or older, representing 45 percent of the total cases.
This malignancy is closely related to age and the incidence rate increases exponentially after the age of 50 years.
The death rate in Indonesia is dominated by non-communicable diseases (PTM).
Furthermore, according to the 2018 Indonesian Basic Health Research, most of NCDs such as cancer, stroke, kidney disease, joint disease, DM, heart disease, hypertension, and overweight/obesity, showed an increasing trend compared to the previous report in 2013.
Dr. Nadia Ayu Mulansari, SpPD-KHOM in her presentation explained that blood cancer can be classified into three groups, namely Lymphoma, Leukemia and Multiple Myeloma.
Read also: PT Johnson & Johnson Indonesia Continues the ‘United Against TB’ Movement by Launching TB Warriors
He said, “The definite cause of the disease cancer blood is still unknown, but is multifactorial. One mechanism that is thought to be related is a decrease in adaptive immunity associated with increasing age so that the risk of experiencing cancer blood will increase in old age. Some of the symptoms that are considered alarm symptoms include recurrent fever and unexplained weight loss. Definitive diagnosis of disease cancer blood will be enforced by a haematologist and medical oncologist.”
Head of Medical Affairs dari PT Johnson & Johnson Indonesia, dr. Rospita Dian further said, “Illness awareness cancer blood generally not as high as the disease cancer solid organs. Cancer blood who often attacks elderly often do not show specific symptoms or signs so that there is a potential for delay in diagnosis. Thus, early detection is very important to get treatment early and regular monitoring to optimize the success of therapy.”
Johnson & Johnson continues to innovate and provide the best for patients, maintain health and create hope for everyone affected cancer and keep trying until you can eliminate cancer. ( Tribunjogja.com )
–
